To The Moon
Home
News
TigerAI
Log In
Sign Up
Yinche
斯坦福PhD
+Follow
Posts · 84
Posts · 84
Following · 0
Following · 0
Followers · 0
Followers · 0
Yinche
Yinche
·
2021-08-13
Fake
Pfizer, Johnson & Johnson, Moderna, who has the highest breakthrough infection rate
突破性感染是指完成疫苗接种超过14天后接种者的新冠病毒检测结果呈阳性。
Pfizer, Johnson & Johnson, Moderna, who has the highest breakthrough infection rate
看
1.39K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-07-15
Not bad，worth reading
Sorry, this post has been deleted
看
1.02K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-06-02
Nothing will happen inside your words.
Sorry, this post has been deleted
看
1.08K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-31
A New Era
Sorry, this post has been deleted
看
1.18K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-25
Attention
Sorry, this post has been deleted
看
1.23K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-15
Not bad，worth reading
Sorry, this post has been deleted
看
869
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-05
Not bad，worth reading
看
794
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-03
TESLA
看
1.31K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Yinche
Yinche
·
2020-05-03
Not bad，worth reading
【圖文直播】巴菲特股東大會的流水賬
@小虎活动：
歡迎來到伯克希爾年會！ 對資本家來說，伍德斯托克的節日這次要低調得多。奧馬哈春運般的人潮消失了，會議期間也沒有糖果和商品銷售了。唯一不變的是巴老爺右手邊的櫻桃可樂。 但是，這次會議比以往任何時候都重要。過去一個月，巴菲特一直相對沉默，這讓人們不禁要問，爲什麼伯克希爾還沒有達成任何大型交易，以及他對美國股市一個多月來的情況有什麼真實感受。 巴菲特和主要副手格雷格•阿貝爾將回答股東提出的問題，這些問題從下午4點45分在奧馬哈(Omaha)由三名精挑細選的記者提交。 在形式上有一些大的變化。查理•芒格(Charlie Munger)不會出現，這是一個巨大的變化，因爲通常是巴菲特/芒格的雙人表演。此外，巴菲特和阿貝爾不會討論政治或具體的投資持股，這是之前會議中經常出現的兩個話題。 週六早些時候，伯克希爾公佈了第一季度的收益，讓我們對該公司迄今爲止如何應對流感疫情有了一點了解。$伯克希爾(BRK.A)$ $伯克希爾B(BRK.B)$ 伯克希爾在投資股市時非常謹慎。該公司僅回購了17億美元的自有股票，並在上個月成爲股票淨出售者(大部分出售發生在4月份)。這意味着伯克希爾現在手頭有超過1,370億美元的現金。 這將是今天的一個大問題。從技術上講，巴菲特在市場低迷時期往往表現最好。他讓伯克希爾成爲一個“金融堡壘”，然後他就可以用多餘的現金收購其他公司，或者投入鉅額資金，獲得利潤豐厚的優先股。 但在這場與大流行有關的危機中，我們真的還沒有看到伯克希爾做了多少事情。就連他的長期商業夥伴查理•芒格上個月也說，伯克希爾的電話並沒有響個不停。 希望我們能聽到更多關於這背後的邏
【圖文直播】巴菲特股東大會的流水賬
看
1.34K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3513721956403904","uuid":"3513721956403904","gmtCreate":1550627937640,"gmtModify":1616987586542,"name":"Yinche","pinyin":"yinche","introduction":"","introductionEn":null,"signature":"斯坦福PhD","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":72,"headSize":277,"tweetSize":84,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":986,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":894508340,"gmtCreate":1628834894180,"gmtModify":1676529869855,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Fake","listText":"Fake","text":"Fake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894508340","repostId":"1159421946","repostType":4,"repost":{"id":"1159421946","kind":"news","pubTimestamp":1628822940,"share":"https://ttm.financial/m/news/1159421946?lang=en_US&edition=fundamental","pubTime":"2021-08-13 10:49","market":"us","language":"zh","title":"Pfizer, Johnson & Johnson, Moderna, who has the highest breakthrough infection rate","url":"https://stock-news.laohu8.com/highlight/detail?id=1159421946","media":"新浪科技","summary":"突破性感染是指完成疫苗接种超过14天后接种者的新冠病毒检测结果呈阳性。","content":"<p>On August 13th, Beijing time, at present, the unvaccinated population accounts for the vast majority of infected patients in Novel Coronavirus in the United States, but what is unexpected is that some infected patients are actually vaccinators. Such cases are called breakthrough infection. Specifically, breakthrough infection refers to the positive Novel Coronavirus test result of the vaccinated person more than 14 days after the vaccination is completed. But does the probability of people developing a breakthrough infection depend on the type of vaccine they receive?</p><p>Simply put, we don't know the exact answer, but there are some hints in the relevant data that Johnson & Johnson's vaccine seems to have a higher breakthrough infection rate than Pfizer and Moderna's vaccines, but this is only based on the expected data of clinical trials. Some previous indications have shown that the breakthrough infection rate of the Moderna vaccine is slightly lower than that of the Pfizer vaccine, but this is only based on data from millions of residents in two regions, so it may not be representative of the actual situation of the whole country.</p><p><img src=\"https://static.tigerbbs.com/a26f0a47e9757331e50c43c5ad2f98d0\" tg-width=\"602\" tg-height=\"340\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Johnson & Johnson's vaccine appears to have a higher breakthrough infection rate than Pfizer, Moderna's, but that's only based on expected data from clinical trials</p><p>Since no vaccine is 100% effective, scientists expected breakthrough infections to appear sooner or later when the vaccine was launched. In clinical trials, the Novel Coronavirus infection rate of people who received the Pfizer vaccine was 0.04%, while that of people who received the Moderna vaccine The infection rate of people who received the vaccine was about 0.07%, and the infection rate of those who received the Johnson & Johnson vaccine was about 0.59%.</p><p>At present, multiple vaccine brands have been authorized and approved, and scientists can track and analyze the real breakthrough infection rate outside clinical trials in real life. When a breakthrough infection occurs, most people will have mild symptoms. If the condition worsens further, some patients need hospitalization and even die.</p><p>However, the recent highly contagious Delta Novel Coronavirus may increase the risk of breakthrough infections. For example, on August 6, the U.S. Centers for Disease Control and Prevention (CDC) published a weekly report on morbidity and mortality (MMWR). The article pointed out that from May to June this year, the number of Delta virus-infected patients in Mesa County, Colorado, USA surged. At the same time, the cumulative proportion of breakthrough infections in the county was \"significantly higher\" than in other parts of the state.</p><p>In a search of information on the websites of state health departments in the United States, researchers found that most of the information reporting breakthrough infection cases appeared on the websites of state health departments. Among the 25 states that reported breakthrough infections, most states did not provide data on the number of cases related to each vaccine brand.</p><p>However, Oklahoma and Washington states in the United States have announced the brands of vaccines that have been injected with breakthrough infections. The Washington State Health website said that these data can provide \"early signals\" about the vaccine work, especially before new virus variants appear, so that researchers can trace and analyze the virus mutation process. At the same time, the current epidemic prevention and control work has also exposed some limitations: there are too few data sets, the number of people vaccinated with each vaccine is different, and the vaccination time is different, so it is difficult to interpret these data.</p><p>Despite this, according to the latest data from the Washington State Health website, as of August 1 this year, more than 299,000 Washington State residents have been fully vaccinated with the Novel Coronavirus vaccine. Among this population, nearly 151,000 people have received two doses of the Pfizer vaccine. About 124,700 people have received two doses of the Moderna vaccine, and about 24,000 people have received one dose of the Johnson & Johnson vaccine.</p><p>Among the breakthrough infection cases, the vaccine brand with the highest probability of breakthrough infection is Johnson & Johnson, with a total of 77 people, accounting for 0.32% of the 24,000 vaccinators; Next is the Pfizer vaccine, with 308 breakthrough infection patients, accounting for 0.2% of 151,000 vaccinators; Then there is the Moderna vaccine, with 161 breakthrough infections after 124,700 people were vaccinated, accounting for 0.13%.</p><p>In fact, this data is still very conservative, and there may be asymptomatic, mild, moderate, and severe breakthrough infection cases. Some asymptomatic or mildly infected people may not have received nucleic acid testing, so their infection status will be omitted, which means This is an insufficient statistical data, and maybe the real data will be very shocking.</p><p>At present, similar data has been reported in Oklahoma, USA. On August 2, more than 1.5 million residents in Oklahoma have been fully vaccinated, about 817,000 people have been vaccinated with Pfizer vaccine, 674,000 people have been vaccinated with Moderna vaccine, and 102,000 people have been vaccinated with Johnson & Johnson vaccine. Similarly, statistics show that patients vaccinated with Johnson & Johnson vaccine have the highest probability of breakthrough infection, with 215 vaccinators testing positive for the virus, accounting for 0.21%; 1,468 Pfizer vaccine recipients experienced breakthrough infections, accounting for 0.17%; At the same time, 831 Moderna vaccine recipients developed breakthrough infections and tested positive for the virus, accounting for 0.12%.</p><p>These are real data from Oklahoma and Washington and may provide an incomplete picture of breakthrough cases in each region, however, it is unclear whether the observed patterns are representative of the country as a whole. Robert Darnell, an internal medicine scientist at Rockefeller University in the United States, said that in order to accurately compare vaccine brands, especially with the widely spread Delta virus variant, we need more data.</p><p>Other preliminary studies suggest the Moderna vaccine offers more protection against the Delta variant than the Pfizer vaccine, which may help explain the difference in breakthrough infection rates. On August 8, the latest statistical research report showed that during the period from January to July, with the emergence of the Delta variant virus, the effectiveness of the Moderna vaccine dropped from 86% to 76%, while the effectiveness of the Pfizer vaccine dropped from 76%.% dropped to 42%. (Ye Qingcheng)</p>","source":"sina_tech","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, Johnson & Johnson, Moderna, who has the highest breakthrough infection rate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, Johnson & Johnson, Moderna, who has the highest breakthrough infection rate\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪科技</strong><span class=\"h-time small\">2021-08-13 10:49</span>\n</p>\n</h4>\n</header>\n<article>\n<p>On August 13th, Beijing time, at present, the unvaccinated population accounts for the vast majority of infected patients in Novel Coronavirus in the United States, but what is unexpected is that some infected patients are actually vaccinators. Such cases are called breakthrough infection. Specifically, breakthrough infection refers to the positive Novel Coronavirus test result of the vaccinated person more than 14 days after the vaccination is completed. But does the probability of people developing a breakthrough infection depend on the type of vaccine they receive?</p><p>Simply put, we don't know the exact answer, but there are some hints in the relevant data that Johnson & Johnson's vaccine seems to have a higher breakthrough infection rate than Pfizer and Moderna's vaccines, but this is only based on the expected data of clinical trials. Some previous indications have shown that the breakthrough infection rate of the Moderna vaccine is slightly lower than that of the Pfizer vaccine, but this is only based on data from millions of residents in two regions, so it may not be representative of the actual situation of the whole country.</p><p><img src=\"https://static.tigerbbs.com/a26f0a47e9757331e50c43c5ad2f98d0\" tg-width=\"602\" tg-height=\"340\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Johnson & Johnson's vaccine appears to have a higher breakthrough infection rate than Pfizer, Moderna's, but that's only based on expected data from clinical trials</p><p>Since no vaccine is 100% effective, scientists expected breakthrough infections to appear sooner or later when the vaccine was launched. In clinical trials, the Novel Coronavirus infection rate of people who received the Pfizer vaccine was 0.04%, while that of people who received the Moderna vaccine The infection rate of people who received the vaccine was about 0.07%, and the infection rate of those who received the Johnson & Johnson vaccine was about 0.59%.</p><p>At present, multiple vaccine brands have been authorized and approved, and scientists can track and analyze the real breakthrough infection rate outside clinical trials in real life. When a breakthrough infection occurs, most people will have mild symptoms. If the condition worsens further, some patients need hospitalization and even die.</p><p>However, the recent highly contagious Delta Novel Coronavirus may increase the risk of breakthrough infections. For example, on August 6, the U.S. Centers for Disease Control and Prevention (CDC) published a weekly report on morbidity and mortality (MMWR). The article pointed out that from May to June this year, the number of Delta virus-infected patients in Mesa County, Colorado, USA surged. At the same time, the cumulative proportion of breakthrough infections in the county was \"significantly higher\" than in other parts of the state.</p><p>In a search of information on the websites of state health departments in the United States, researchers found that most of the information reporting breakthrough infection cases appeared on the websites of state health departments. Among the 25 states that reported breakthrough infections, most states did not provide data on the number of cases related to each vaccine brand.</p><p>However, Oklahoma and Washington states in the United States have announced the brands of vaccines that have been injected with breakthrough infections. The Washington State Health website said that these data can provide \"early signals\" about the vaccine work, especially before new virus variants appear, so that researchers can trace and analyze the virus mutation process. At the same time, the current epidemic prevention and control work has also exposed some limitations: there are too few data sets, the number of people vaccinated with each vaccine is different, and the vaccination time is different, so it is difficult to interpret these data.</p><p>Despite this, according to the latest data from the Washington State Health website, as of August 1 this year, more than 299,000 Washington State residents have been fully vaccinated with the Novel Coronavirus vaccine. Among this population, nearly 151,000 people have received two doses of the Pfizer vaccine. About 124,700 people have received two doses of the Moderna vaccine, and about 24,000 people have received one dose of the Johnson & Johnson vaccine.</p><p>Among the breakthrough infection cases, the vaccine brand with the highest probability of breakthrough infection is Johnson & Johnson, with a total of 77 people, accounting for 0.32% of the 24,000 vaccinators; Next is the Pfizer vaccine, with 308 breakthrough infection patients, accounting for 0.2% of 151,000 vaccinators; Then there is the Moderna vaccine, with 161 breakthrough infections after 124,700 people were vaccinated, accounting for 0.13%.</p><p>In fact, this data is still very conservative, and there may be asymptomatic, mild, moderate, and severe breakthrough infection cases. Some asymptomatic or mildly infected people may not have received nucleic acid testing, so their infection status will be omitted, which means This is an insufficient statistical data, and maybe the real data will be very shocking.</p><p>At present, similar data has been reported in Oklahoma, USA. On August 2, more than 1.5 million residents in Oklahoma have been fully vaccinated, about 817,000 people have been vaccinated with Pfizer vaccine, 674,000 people have been vaccinated with Moderna vaccine, and 102,000 people have been vaccinated with Johnson & Johnson vaccine. Similarly, statistics show that patients vaccinated with Johnson & Johnson vaccine have the highest probability of breakthrough infection, with 215 vaccinators testing positive for the virus, accounting for 0.21%; 1,468 Pfizer vaccine recipients experienced breakthrough infections, accounting for 0.17%; At the same time, 831 Moderna vaccine recipients developed breakthrough infections and tested positive for the virus, accounting for 0.12%.</p><p>These are real data from Oklahoma and Washington and may provide an incomplete picture of breakthrough cases in each region, however, it is unclear whether the observed patterns are representative of the country as a whole. Robert Darnell, an internal medicine scientist at Rockefeller University in the United States, said that in order to accurately compare vaccine brands, especially with the widely spread Delta virus variant, we need more data.</p><p>Other preliminary studies suggest the Moderna vaccine offers more protection against the Delta variant than the Pfizer vaccine, which may help explain the difference in breakthrough infection rates. On August 8, the latest statistical research report showed that during the period from January to July, with the emergence of the Delta variant virus, the effectiveness of the Moderna vaccine dropped from 86% to 76%, while the effectiveness of the Pfizer vaccine dropped from 76%.% dropped to 42%. (Ye Qingcheng)</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://finance.sina.com.cn/tech/2021-08-13/doc-ikqcfncc2581219.shtml\">新浪科技</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/74edb15d6940266504a200876297ca1a","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","JNJ":"强生"},"source_url":"https://finance.sina.com.cn/tech/2021-08-13/doc-ikqcfncc2581219.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159421946","content_text":"北京时间8月13日消息，目前，未接种疫苗人群占美国新冠病毒感染患者的绝大多数，但令人始料不及的是，一部分感染患者竟然是疫苗接种者，这样的病例被称为突破性感染，具体地讲，突破性感染是指完成疫苗接种超过14天后接种者的新冠病毒检测结果呈阳性。但是，人们出现突破性感染的概率是否取决于他们接种的疫苗类型？\n简单地讲，我们并不知道确切的答案，但相关数据中有一些提示，强生公司的疫苗似乎比辉瑞、Moderna公司的疫苗具有更高的突破性感染率，但这仅是基于临床试验的预期数据。之前一些迹象显示，Moderna疫苗的突破性感染率略低于辉瑞疫苗，但这仅是基于来自两个地区数百万居民的数据，因此可能无法代表整个国家的实际情况。\n强生公司的疫苗似乎比辉瑞、Moderna公司的疫苗具有更高的突破性感染率，但这仅是基于临床试验的预期数据\n由于没有哪一种疫苗是100%有效的，因此科学家在疫苗推出之时就预期到突破性感染迟早会出现，在临床试验中，注射辉瑞疫苗的人群新冠病毒感染率为0.04%，而注射Moderna疫苗的人群感染率约0.07%，注射强生疫苗的人群感染率约0.59%。\n目前多个疫苗品牌已授权获批，科学家就能在现实生活中跟踪分析临床试验之外的真实突破性感染率，当突破性感染发生时，大多数人会出现轻微症状，如果病情进一步恶化，部分患者需要住院治疗，甚至会死亡。\n然而，近期高传染性的德尔塔新冠病毒可能会增大突破性感染的风险，例如：8月6日美国疾病控制和预防中心（CDC）发表一篇发病率和死亡率周报（MMWR），文中指出，今年5-6月，美国科罗拉多州梅萨县的德尔塔病毒感染患者激增，与此同时，该县累计的突破性感染病例比例“明显高于”该州其他地区。\n研究人员在对美国各州卫生部门网站的信息搜索中发现，报道出现突破性感染病例的信息大多出现在州政府的卫生部门网站，在报道出现突破性感染的25个州中，大多数州并未提供与每种疫苗品牌相关的病例数量相关数据。\n然而，美国俄克拉荷马州和华盛顿州公布了突破性感染病例曾注射的疫苗品牌，华盛顿州卫生健康网站称，这些数据可提供有关疫苗工作情况的“早期信号”，特别是在新的病毒变种出现之前，便于研究人员追溯分析病毒变异过程。同时，当前的疫情防控工作还暴露出一些局限性：掌握的数据集太少，每种疫苗接种人数不同，而且接种时间不同，因此很难解释这些数据。\n尽管如此，依据华盛顿州卫生健康网站最新数据，截至今年8月1日，超过29.9万名华盛顿州居民已全面接种新冠病毒疫苗，在该人群中，接近15.1万人接种了两剂辉瑞疫苗，大约12.47万人接种了两剂Moderna疫苗，大约2.4万人接种了一剂强生疫苗。\n在突破性感染病例中，发生突破性感染概率最高的疫苗品牌是强生公司，共77人，占2.4万接种者0.32%；接下来是辉瑞疫苗，突破性感染患者308人，占15.1万接种者0.2%；然后是Moderna疫苗，12.47万人接种后出现161人突破性感染，占比0.13%。\n事实上，该数据仍十分保守，还可能存在无症状、轻、中、重度突破性感染病例，一些无症状或者轻微感染人群可能未接受核酸检测，因此他们的感染情况会被遗漏，意味着这是一个未充分统计的数据，也许真实数据会令人十分震惊。\n目前，美国俄克拉荷马州也报道了类似的数据，8月2日，俄克拉150万以上居民已全面接种疫苗，大约81.7万人接种辉瑞疫苗，67.4万人接种Moderna疫苗，10.2万人接种强生疫苗。同样，统计数据显示，接种强生疫苗的患者出现突破性感染概率最高，有215位接种者病毒检测呈阳性，占比0.21%；辉瑞疫苗接种者出现突破性感染者1468人，占比0.17%；同时，831名Moderna疫苗接种者出现突破性感染，病毒检测呈阳性，占比0.12%。\n这些是来自俄克拉荷马州和华盛顿州的真实数据，可能提供了每个地区突破性病例的不完整图景，然而，目前还不清楚观察到的模式是否代表整个国家。美国洛克菲勒大这内科科学家罗伯特·达内尔称，为了准确地比较疫苗品牌，特别是与传播广泛的德尔塔病毒变种进行数据比较，我们需要更多的数据。\n其他初步研究表明，Moderna疫苗比辉瑞疫苗对德尔塔病毒变种提供了更多的保护，这可能有助于解释突破性感染比率的差异。8月8日，最新一项统计研究报告显示，1-7月期间，伴随着德尔塔变种病毒出现，Moderna疫苗的有效性从86%下降至76%，同时，辉瑞疫苗的有效性从76%下降至42%。（叶倾城）","news_type":1,"symbols_score_info":{"MRNA":0.9,"PFE":0.9,"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":1391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":941129292,"gmtCreate":1594826231916,"gmtModify":1705046745217,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Not bad，worth reading","listText":"Not bad，worth reading","text":"Not bad，worth reading","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/941129292","repostId":"2051440295","repostType":4,"isVote":1,"tweetType":1,"viewCount":1018,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":958009098,"gmtCreate":1591088219014,"gmtModify":1705314073340,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Nothing will happen inside your words.","listText":"Nothing will happen inside your words.","text":"Nothing will happen inside your words.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/958009098","repostId":"1126351013","repostType":4,"isVote":1,"tweetType":1,"viewCount":1076,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":951271818,"gmtCreate":1590910563134,"gmtModify":1705313666393,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"A New Era","listText":"A New Era","text":"A New Era","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/951271818","repostId":"1110045599","repostType":4,"isVote":1,"tweetType":1,"viewCount":1175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":953623021,"gmtCreate":1590370418263,"gmtModify":1705312222134,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Attention","listText":"Attention","text":"Attention","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/953623021","repostId":"2037546044","repostType":2,"isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":950440014,"gmtCreate":1589498927238,"gmtModify":1705310042033,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Not bad，worth reading","listText":"Not bad，worth reading","text":"Not bad，worth reading","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/950440014","repostId":"1124635934","repostType":4,"isVote":1,"tweetType":1,"viewCount":869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":927918718,"gmtCreate":1588692959134,"gmtModify":1705307782960,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Not bad，worth reading","listText":"Not bad，worth reading","text":"Not bad，worth reading","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/927918718","repostId":"20200504233507450","repostType":13,"repost":{"supObjectId":"C20200504233022336","supType":16,"sup_object_id":"C20200504233022336","sup_type":"C20200504233022336"},"isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":924566240,"gmtCreate":1588473033380,"gmtModify":1705307287921,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"TESLA","listText":"TESLA","text":"TESLA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/924566240","isVote":1,"tweetType":1,"viewCount":1313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":924561269,"gmtCreate":1588471448151,"gmtModify":1705307289733,"author":{"id":"3513721956403904","authorId":"3513721956403904","name":"Yinche","avatar":"https://static.tigerbbs.com/21c9d4c4c232c51723c2e66d956d875f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3513721956403904","idStr":"3513721956403904"},"themes":[],"htmlText":"Not bad，worth reading","listText":"Not bad，worth reading","text":"Not bad，worth reading","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/924561269","repostId":"924583559","repostType":1,"repost":{"id":924583559,"gmtCreate":1588454191949,"gmtModify":1705307272435,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/44a4f89726b3f6319d06a0075bf9ff76","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"【圖文直播】巴菲特股東大會的流水賬","htmlText":"歡迎來到伯克希爾年會！ 對資本家來說，伍德斯托克的節日這次要低調得多。奧馬哈春運般的人潮消失了，會議期間也沒有糖果和商品銷售了。唯一不變的是巴老爺右手邊的櫻桃可樂。 但是，這次會議比以往任何時候都重要。過去一個月，巴菲特一直相對沉默，這讓人們不禁要問，爲什麼伯克希爾還沒有達成任何大型交易，以及他對美國股市一個多月來的情況有什麼真實感受。 巴菲特和主要副手格雷格•阿貝爾將回答股東提出的問題，這些問題從下午4點45分在奧馬哈(Omaha)由三名精挑細選的記者提交。 在形式上有一些大的變化。查理•芒格(Charlie Munger)不會出現，這是一個巨大的變化，因爲通常是巴菲特/芒格的雙人表演。此外，巴菲特和阿貝爾不會討論政治或具體的投資持股，這是之前會議中經常出現的兩個話題。 週六早些時候，伯克希爾公佈了第一季度的收益，讓我們對該公司迄今爲止如何應對流感疫情有了一點了解。<a target=\"_blank\" href=\"https://laohu8.com/S/BRK.A\">$伯克希爾(BRK.A)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/BRK.B\">$伯克希爾B(BRK.B)$</a> 伯克希爾在投資股市時非常謹慎。該公司僅回購了17億美元的自有股票，並在上個月成爲股票淨出售者(大部分出售發生在4月份)。這意味着伯克希爾現在手頭有超過1,370億美元的現金。 這將是今天的一個大問題。從技術上講，巴菲特在市場低迷時期往往表現最好。他讓伯克希爾成爲一個“金融堡壘”，然後他就可以用多餘的現金收購其他公司，或者投入鉅額資金，獲得利潤豐厚的優先股。 但在這場與大流行有關的危機中，我們真的還沒有看到伯克希爾做了多少事情。就連他的長期商業夥伴查理•芒格上個月也說，伯克希爾的電話並沒有響個不停。 希望我們能聽到更多關於這背後的邏","listText":"歡迎來到伯克希爾年會！ 對資本家來說，伍德斯托克的節日這次要低調得多。奧馬哈春運般的人潮消失了，會議期間也沒有糖果和商品銷售了。唯一不變的是巴老爺右手邊的櫻桃可樂。 但是，這次會議比以往任何時候都重要。過去一個月，巴菲特一直相對沉默，這讓人們不禁要問，爲什麼伯克希爾還沒有達成任何大型交易，以及他對美國股市一個多月來的情況有什麼真實感受。 巴菲特和主要副手格雷格•阿貝爾將回答股東提出的問題，這些問題從下午4點45分在奧馬哈(Omaha)由三名精挑細選的記者提交。 在形式上有一些大的變化。查理•芒格(Charlie Munger)不會出現，這是一個巨大的變化，因爲通常是巴菲特/芒格的雙人表演。此外，巴菲特和阿貝爾不會討論政治或具體的投資持股，這是之前會議中經常出現的兩個話題。 週六早些時候，伯克希爾公佈了第一季度的收益，讓我們對該公司迄今爲止如何應對流感疫情有了一點了解。<a target=\"_blank\" href=\"https://laohu8.com/S/BRK.A\">$伯克希爾(BRK.A)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/BRK.B\">$伯克希爾B(BRK.B)$</a> 伯克希爾在投資股市時非常謹慎。該公司僅回購了17億美元的自有股票，並在上個月成爲股票淨出售者(大部分出售發生在4月份)。這意味着伯克希爾現在手頭有超過1,370億美元的現金。 這將是今天的一個大問題。從技術上講，巴菲特在市場低迷時期往往表現最好。他讓伯克希爾成爲一個“金融堡壘”，然後他就可以用多餘的現金收購其他公司，或者投入鉅額資金，獲得利潤豐厚的優先股。 但在這場與大流行有關的危機中，我們真的還沒有看到伯克希爾做了多少事情。就連他的長期商業夥伴查理•芒格上個月也說，伯克希爾的電話並沒有響個不停。 希望我們能聽到更多關於這背後的邏","text":"歡迎來到伯克希爾年會！ 對資本家來說，伍德斯托克的節日這次要低調得多。奧馬哈春運般的人潮消失了，會議期間也沒有糖果和商品銷售了。唯一不變的是巴老爺右手邊的櫻桃可樂。 但是，這次會議比以往任何時候都重要。過去一個月，巴菲特一直相對沉默，這讓人們不禁要問，爲什麼伯克希爾還沒有達成任何大型交易，以及他對美國股市一個多月來的情況有什麼真實感受。 巴菲特和主要副手格雷格•阿貝爾將回答股東提出的問題，這些問題從下午4點45分在奧馬哈(Omaha)由三名精挑細選的記者提交。 在形式上有一些大的變化。查理•芒格(Charlie Munger)不會出現，這是一個巨大的變化，因爲通常是巴菲特/芒格的雙人表演。此外，巴菲特和阿貝爾不會討論政治或具體的投資持股，這是之前會議中經常出現的兩個話題。 週六早些時候，伯克希爾公佈了第一季度的收益，讓我們對該公司迄今爲止如何應對流感疫情有了一點了解。$伯克希爾(BRK.A)$ $伯克希爾B(BRK.B)$ 伯克希爾在投資股市時非常謹慎。該公司僅回購了17億美元的自有股票，並在上個月成爲股票淨出售者(大部分出售發生在4月份)。這意味着伯克希爾現在手頭有超過1,370億美元的現金。 這將是今天的一個大問題。從技術上講，巴菲特在市場低迷時期往往表現最好。他讓伯克希爾成爲一個“金融堡壘”，然後他就可以用多餘的現金收購其他公司，或者投入鉅額資金，獲得利潤豐厚的優先股。 但在這場與大流行有關的危機中，我們真的還沒有看到伯克希爾做了多少事情。就連他的長期商業夥伴查理•芒格上個月也說，伯克希爾的電話並沒有響個不停。 希望我們能聽到更多關於這背後的邏","images":[{"img":"https://static.tigerbbs.com/e2e1a12abfb1d56856129804d71605ba"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/924583559","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}